Fatalities During Remission of Childhood Leukemia

Author:

Simone Joseph V.12,Holland Elizabeth13,Johnson Warren14

Affiliation:

1. Hematology, Pediatrics and Pathology Services, St. Jude Children’s Research Hospital, Memphis, Tenn., and the Departments of Pediatrics and Pathology, The University of Tennessee Medical Units, Memphis, Tenn.

2. St. Jude Children's Research Hospital, Memphis, Tenn., and Assistant Professor of Pediatrics, University of Tennessee Medical Units, Memphis, Tenn. Elizabeth Holland, M.D.: Trainee in Pediatrics, St. Jude Children's Research Hospital, Memphis, Tenn.

3. St. Jude Children's Research Hospital, Memphis, Tenn.

4. St. Jude Children's Research Hospital, Memphis, Tenn. University of Tennessee Medical Units, Memphis, Tenn.

Abstract

Abstract The purpose of this study is to determine the frequency, causes, and circumstances of death during remission of childhood leukemia and to delineate predisposing or contributing factors. While overall mortality has decreased, the frequency of remission fatalities at this institution has increased progressively to l6% of all children dying with acute lymphocytic leukemia. This increase coincides with more aggressive therapy, longer remissions and survival, and a larger patient population at risk. The primary causes of death were nonbacterial infections in 23 of the 26 children. Pneumocystis carinii, herpesviruses, cytomegalovirus, and fungi were the principal microorganisms. All but two patients had received intensive combination chemotherapy, and 20 of 26 had received radiotherapy. All patients had experienced hematologic and other toxicity, but severe leukopenia and granulocytopenia did not correlate with the onset of terminal illness. A frequent side effect of therapy was failure to gain weight. Most patients had potentially fatal infections prior to the terminal illness. Despite complete clinical remission for at least 1 mo before death, leukemia was found at autopsy in nine of 20 patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 146 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3